The document describes a Gleason grade grouping system used to classify prostate cancer based on biopsy results. It assigns prostate cancers a grade from 1 to 5 based on their Gleason scores, with lower grades indicating less aggressive cancers and higher grades indicating more aggressive cancers likely to spread.